GLP-1 agonists — including semaglutides like Ozempic and Wegovy and tirzepatides like Mounjaro and Zepbound — were originally intended to treat type 2 diabetes and obesity. But in recent months, studies have shown that these popular medications can have numerous other health benefits. Some have even claimed that GLP-1s could …
Read More »
As demand for GLP-1 medications continues to skyrocket for weight loss and diabetes, more Americans are skipping pharmacies and turning to unregulated sellers as a way to avoid high prices, insurance barriers and recurring shortages. The U.S. Food and Drug Administration has warned that so-called “gray market” GLP-1s (such as …
Read More »
Amy Schumer isn’t hiding behind filters. The 44-year-old comedian showed off her flat abs in a mirror selfie this week, rocking a sports bra and dark-colored pants while keeping things candid with her fans. Her social media caption read, “No filter, no filler, no clean mirror.” In the photo, Schumer …
Read More »